- Patent Title: Systems and methods for identifying HLA-associated tumor peptides
-
Application No.: US18343260Application Date: 2023-06-28
-
Publication No.: US12135327B2Publication Date: 2024-11-05
- Inventor: Robert Salzler
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: McCarter & English, LLP
- Agent Marcie B. Clarke
- Main IPC: G01N33/68
- IPC: G01N33/68 ; C07K1/22 ; C07K1/36 ; C40B30/04 ; G01N33/569

Abstract:
Systems and methods for determining amino acid sequences of peptides that bind to MHC-I or HLA-I complex or MHC-II or HLA-II complex are provided. One embodiment includes isolating peptides from MHC or HLA class I or class II-peptide complexes and adding one or more known labeled peptides of interest to form a sample containing labeled peptides and unlabeled isolated peptides. The method also includes analyzing the sample with an LC-MS/MS system to obtain sequence data of the peptides, and increasing the sensitivity of the LC-MS/MS system when the labeled peptide is detected by the LC-MS/MS system. The method then concludes with determining the amino acid sequence of the unlabeled peptides in an m/z range that includes the m/z of the labeled peptide. The system can be triggered to increase the sensitivity in or near the m/z of the labeled peptide using an algorithm or computer program.
Public/Granted literature
- US20230417757A1 SYSTEMS AND METHODS FOR IDENTIFYING HLA-ASSOCIATED TUMOR PEPTIDES Public/Granted day:2023-12-28
Information query
IPC分类: